Search

Home > GRACEcast Lung Cancer Video > Clinical Trial Spotlight: ALCHEMIST for Early-Stage ALK+ and EGFR Lung Cancer Patients
Podcast: GRACEcast Lung Cancer Video
Episode:

Clinical Trial Spotlight: ALCHEMIST for Early-Stage ALK+ and EGFR Lung Cancer Patients
Category: Science & Medicine
Duration: 00:04:19
Publish Date: 2015-11-06 14:00:00
Description:

Dr. Nathan Pennell discusses ALCHEMIST, an NCI-sponsored clinical trial looking at whether targeted post-op (adjuvant) therapy for patients with a driver mutation such as EGFR mutation or ALK rearrangement improves survival. http://bit.ly/NCIALCHEMIST
Total Play: 0